1113 related articles for article (PubMed ID: 29970076)
1. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
[TBL] [Abstract][Full Text] [Related]
2. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.
Alene KA; Viney K; McBryde ES; Gray DJ; Melku M; Clements ACA
Transbound Emerg Dis; 2019 Jul; 66(4):1611-1618. PubMed ID: 30924283
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
Welekidan LN; Skjerve E; Dejene TA; Gebremichael MW; Brynildsrud O; Agdestein A; Tessema GT; Tønjum T; Yimer SA
PLoS One; 2020; 15(8):e0236362. PubMed ID: 32797053
[TBL] [Abstract][Full Text] [Related]
6. Multi-drug-resistant tuberculosis and its associated factors among pulmonary tuberculosis patients linked to first-line anti-tuberculosis drugs in north-west Ethiopia.
Erkihun M; Kiros T; Berhan A; Ayele B
J Med Microbiol; 2023 Dec; 72(12):. PubMed ID: 38099651
[No Abstract] [Full Text] [Related]
7. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
Woldeyohannes D; Assefa T; Aman R; Tekalegn Y; Hailemariam Z
PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.
Adane K; Ameni G; Bekele S; Abebe M; Aseffa A
BMC Public Health; 2015 Jun; 15():572. PubMed ID: 26092570
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia.
Desissa F; Workineh T; Beyene T
BMC Public Health; 2018 Apr; 18(1):422. PubMed ID: 29606112
[TBL] [Abstract][Full Text] [Related]
10. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study.
Hirpa S; Medhin G; Girma B; Melese M; Mekonen A; Suarez P; Ameni G
BMC Public Health; 2013 Aug; 13():782. PubMed ID: 23981845
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study.
Admassu F; Abera E; Gizachew A; Sedoro T; Gari T
BMJ Open; 2023 Jan; 13(1):e061836. PubMed ID: 36639214
[TBL] [Abstract][Full Text] [Related]
12. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
Shibabaw A; Gelaw B; Wang SH; Tessema B
PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
[TBL] [Abstract][Full Text] [Related]
13. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
14. Predictors of multidrug resistant tuberculosis among adult patients at Saint Peter Hospital Addis Ababa, Ethiopia.
Dessalegn M; Daniel E; Behailu S; Wagnew M; Nyagero J
Pan Afr Med J; 2016; 25(Suppl 2):5. PubMed ID: 28439330
[TBL] [Abstract][Full Text] [Related]
15. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.
Hanrahan CF; Dorman SE; Erasmus L; Koornhof H; Coetzee G; Golub JE
PLoS One; 2012; 7(11):e49898. PubMed ID: 23226229
[TBL] [Abstract][Full Text] [Related]
16. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated with Multi-Drug Resistant Tuberculosis among TB Patients in Selected Treatment Centers of Amhara Region: A Case-Control Study.
Ambaye GY; Tsegaye GW
Ethiop J Health Sci; 2021 Jan; 31(1):25-34. PubMed ID: 34158749
[TBL] [Abstract][Full Text] [Related]
18. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013-2017.
Okethwangu D; Birungi D; Biribawa C; Kwesiga B; Turyahabwe S; Ario AR; Zhu BP
BMC Infect Dis; 2019 May; 19(1):387. PubMed ID: 31064332
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia.
Demile B; Zenebu A; Shewaye H; Xia S; Guadie A
BMC Infect Dis; 2018 May; 18(1):249. PubMed ID: 29855354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
